GHNO Growth Hormone News Online

Growth hormone (GH) or somatotropin (STH) is a protein hormone which stimulates growth and cell reproduction in humans and other animals. It is a 191-amino acid, single chain polypeptide hormone which is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland.

This article describes growth hormone physiology, with brief mentions of the diseases of GH deficiency, GH excess (acromegaly and pituitary gigantism), as well as GH treatment. For information on a common growth hormone sometimes given to cows, see bovine somatotropin.

Terminology
See articles on GH treatment for more complete discussions of GH therapy and the HGH issue.
Growth hormone (GH) is also called "somatotropin" (British: "somatotrophin").

"hGH" refers to human growth hormone and is an abbreviation for human GH secreted by, or measured in extracts from, human pituitary glands.

In 1985, biosynthetic human growth hormone replaced pituitary-derived human growth hormone for therapeutic use in the U.S. and elsewhere. Biosynthetic human growth hormone, also referred to as recombinant human growth hormone, is also called "somatropin" and abbreviated as "rhGH".

Since the mid-1980s the abbreviation HGH has begun to carry paradoxical connotations, and now rarely refers to real GH used for indicated purposes.

Structure and gene of the human GH molecule
The genes for human growth hormone are localized in the q22-24 region of chromosome 17 (GH1) and are closely related to human chorionic somatomammotropin (hCS, also known as placental lactogen) genes. GH, human chorionic somatomammotropin (hCS), and prolactin (PRL) are a group of homologous hormones with growth-promoting and lactogenic activity.

The major isoform of the human growth hormone is a protein of 191 amino acids and a molecular weight of about 22,000 daltons. The structure includes four helices necessary for functional interaction with the GH receptor. GH is structurally and apparently evolutionarily homologous to prolactin and chorionic somatomammotropin. Despite marked structural similarities between growth hormone from different species, only human and primate growth hormones have significant effects in humans.

Secretion of GH
Several molecular forms of GH circulate. Much of the growth hormone in the circulation is bound to a protein (growth hormone binding protein, GHBP) which is derived from the growth hormone receptor.

GH is secreted into the blood by the somatotrope cells of the anterior pituitary gland, in larger amounts than any other pituitary hormone. Secretion levels are highest during puberty. The transcription factor PIT-1 stimulates both the development of these cells and their production of GH. Failure of development of these cells, as well as destruction of the anterior pituitary gland, results in GH deficiency.

Regulation
Peptides released by neurosecretory nuclei of the hypothalamus into the portal venous blood surrounding the pituitary are the major controllers of GH secretion by the somatotropes. However, although the balance of these stimulating and inhibiting peptides determines GH release, this balance is affected by many physiological stimulators and inhibitors of GH secretion.

Stimulators of GH secretion include:

growth hormone releasing hormone (GHRH) from the arcuate nucleus
ghrelin
sleep
exercise
low levels of blood sugar (hypoglycemia)
dietary protein
estradiol
arginine
Inhibitors of GH secretion include:

somatostatin from the periventricular nucleus
circulating concentrations of GH and IGF-1 (negative feedback)
dietary carbohydrate
glucocorticoids
In addition to control by endogenous processes, a number of foreign compounds (xenobiotics) are now known to influence GH secretion and function , highlighting the fact that the GH-IGF axis is an emerging target for certain endocrine disrupting chemicals ( see endocrine disruptor).

Secretion patterns
Most of the physiologically important secretion occurs as several large pulses or peaks of GH release each day. The plasma concentration of GH during these peaks may range from 5 to 35 ng/mL or more. Peaks typically last from 10 to 30 minutes before returning to basal levels. The largest and most predictable of these GH peaks occurs about an hour after onset of sleep. Otherwise there is wide variation between days and individuals. Between the peaks, basal GH levels are low, usually less than 3 ng/mL for most of the day and night.

The amount and pattern of GH secretion change throughout life. Basal levels are highest in early childhood. The amplitude and frequency of peaks is greatest during the pubertal growth spurt. Healthy children and adolescents average about 8 peaks per 24 hours. Adults average about 5 peaks. Basal levels and the frequency and amplitude of peaks decline throughout adult life.

Functions of GH
Effects of growth hormone on the tissues of the body can generally be described as anabolic (building up). Like most other protein hormones GH acts by interacting with a specific receptor on the surface of cells.

Increasing height
Height growth in childhood is the best known effect of GH action, and appears to be stimulated by at least two mechanisms.

GH directly stimulates division and multiplication of chondrocytes of cartilage. These are the primary cells in the growing ends (epiphyses) of children's long bones (arms, legs, digits).
GH also stimulates production of insulin-like growth factor 1 (IGF-1, formerly known as somatomedin C), a hormone homologous to proinsulin. The liver is a major target organ of GH for this process, and is the principal site of IGF-1 production. IGF-1 has growth-stimulating effects on a wide variety of tissues. Additional IGF-1 is generated within target tissues, making it apparently both an endocrine and an autocrine/paracrine hormone. IGF-1 also has stimulatory effects on osteoblast and chondrocyte activity to promote bone growth.

Other functions
Although height growth is the best known effect of GH, it serves many other metabolic functions as well.

It increases calcium retention, and strengthens and increases the mineralization of bone.
It increases muscle mass through the creation of new muscle cells (i.e. hyperplasia, which differs from hypertrophy)
It promotes lipolysis, which results in the reduction of adipose tissue (body fat).
It increases protein synthesis and stimulates the growth of all internal organs excluding the brain.
It plays a role in fuel homeostasis.
It reduces liver uptake of glucose, an effect that opposes that of insulin.
It promotes liver gluconeogenesis.
It contributes to the maintenance and function of pancreatic islets.
It stimulates the immune system.

Clinical problems: too much and too little

Growth hormone excess: (acromegaly and pituitary gigantism)
The most common disease of GH excess is a pituitary tumor comprised of somatotroph cells of the anterior pituitary. These somatotroph adenomas are benign and grow slowly, gradually producing more and more GH. For years, the principal clinical problems are those of GH excess. Eventually the adenoma may become large enough to cause headaches, impair vision by pressure on the optic nerves, or cause deficiency of other pituitary hormones by displacement.

Prolonged GH excess thickens the bones of the jaw, fingers and toes. Resulting heaviness of the jaw and increased thickness of digits is referred to as acromegaly. Accompanying problems can include pressure on nerves (e.g., carpal tunnel syndrome), muscle weakness, insulin resistance or even a rare form of type 2 diabetes, and reduced sexual function.

GH-secreting tumors are typically recognized in the 5th decade of life. It is extremely rare for such a tumor to occur in childhood, but when it does the excessive GH can cause excessive growth, traditionally referred to as pituitary gigantism.

Surgical removal is the usual treatment for GH-producing tumors. In some circumstances focused radiation or a GH antagonist such as bromocriptine or octreotide may be employed to shrink the tumor or block function.

Growth hormone deficiency (GHD)
Deficiency of GH produces significantly different problems at various ages. In children, growth failure and short stature are the major manifestations of GH deficiency. In adults the effects of deficiency are more subtle, and may include deficiencies of strength, energy, and bone mass, as well as increased cardiovascular risk.

There are many causes of GH deficiency, including mutations of specific genes, congenital malformations involving the hypothalamus and/or pituitary gland, and damage to the pituitary from injury, surgery or disease.

Diagnosis of GH deficiency involves a multiple step diagnostic process, usually culminating in GH stimulation test(s) to see if the patient's pituitary gland will release a pulse of GH when provoked by various stimuli.

GH deficiency is treated by replacing GH. All GH in current use is a biosynthetic version of human GH, manufactured by recombinant DNA technology. As GH is a large protein molecule, it must be injected into subcutaneous tissue to get it into the blood (injections no longer have to enter muscle mass since 1985 with the production of synthetic GH). When the patient has had a long-standing deficiency of GH, benefits of treatment are often dramatic and gratifying and side effects of treatment are rare. Increased growth in childhood can result in dramatically improved adult height.

GH is used as replacement therapy in adults with GH deficiency of either childhood-onset (after completing growth phase) or adult-onset (usually as a result of an acquired pituitary tumor). In these patients, benefits have variably included reduced fat mass, increased lean mass, increased bone density, improved lipid profile, reduced cardiovascular risk factors, and improved psychosocial well-being.

This topic is treated more fully in the articles growth hormone deficiency and growth hormone treatment.

Therapeutic use of growth hormone

Other GH uses and treatment indications
Many other conditions besides GH deficiency cause poor growth, but growth benefits (height gains) are often poorer than when GH deficiency is treated. Examples of other causes of shortness often treated with growth hormone are Turner syndrome, chronic renal failure, Prader-Willi syndrome, intrauterine growth retardation, and severe idiopathic short stature. Higher ("pharmacologic") doses are required to produce significant acceleration of growth in these conditions, producing blood levels well above physiologic. Despite the higher doses, side effects during treatment are rare, and vary little according to the condition being treated.

Sometimes GH is used for benefits other than increasing height. GH treatment improves muscle strength and slightly reduces body fat in Prader-Willi syndrome, benefits more important to these children than increased height. It has also been shown to help maintain muscle mass in AIDS wasting. GH can also be used in patients with short bowel syndrome to lessen the requirement for intravenous total parenteral nutrition.

Uses that are controversial include

GH treatment for remission of Multiple sclerosis
GH treatment to reverse effects of ageing in older adults (see below)
GH treatment to enhance weight loss in obesity
GH treatment for fibromyalgia
GH treatment for Crohn's disease and ulcerative colitis
GH treatment for idiopathic short stature
GH treatment for bodybuilding or athletic enhancement

Anti-aging agent
Claims for GH as an anti-aging treatment date back to 1990 when the New England Journal of Medicine published a study where GH was used to treat 12 men over 60. At the conclusion of the study all the men showed statistically significant increases in lean body mass and bone mineral, while the control group did not. The authors of the study noted that these were the kind of changes that would occur naturally over a 10 to 20 year aging period. Despite the fact the authors at no time claimed that GH had reversed the aging process itself, their results were mis-interpreted as indicating GH was an effective anti-aging agent.

A Stanford University School of Medicine survey of clinical studies on the subject published in early 2007 showed that the application of GH on healthy elderly patients increased muscle by about 2 kg and decreased body fat by the same amount. However, these were the only positive effects from taking GH. No other critical factors were affected, such as bone density, cholesterol levels, lipid measurements, maximal oxygen consumption, or any other factor that would indicate increased fitness. Researchers also didn't discover any gain in muscle strength, which led them to believe that GH merely let the body store more water in the muscles rather than increase muscle growth. This would explain the increase in lean body mass. Regular application of GH did show several negative side effects such as joint swelling, joint pain, carpal tunnel syndrome, and an increased risk of diabetes.

Risks and side effects of GH treatment
Side effects in adults may include fluid retention, joint pain, and nerve compression symptoms. There is theoretical concern that GH treatment may increase the risks of diabetes or cancer, especially in those with other predispositions treated with higher doses. It is pointed out, however, that diabetes is a disease that develops over perhaps 30 or 40 years of poor eating habits, and the most likely cause of diabetes is the poor nutrition which the patient had prior to the use of growth hormone. One survey of adults who had been treated with replacement cadaver GH (which has not been used anywhere in the world, since 1985) during childhood showed a mildly increased incidence of colon cancer, but linkage with the GH treatment was not established.

History
The identification, purification and later synthesis of growth hormone is associated with Choh Hao Li. The history of GH use, from extraction of GH from human pituitary glands to the limited catastrophe of Creutzfeldt-Jakob Disease to the expanded use and enormous costs of synthetic GH is outlined in the article on GH treatment.

As of 2005, synthetic growth hormones available in the United States (and their manufacturers) included Nutropin (Genentech), Humatrope (Lilly), Genotropin (Pfizer), Norditropin (Novo), and Saizen (Merck Serono). The products are nearly identical in composition, efficacy, and cost, varying primarily in the formulations and delivery devices. In 2005 an Israeli company, Teva, offered Tev-Tropin in the U.S. at a lower price. In 2006, the U.S. Food and Drug Association (FDA) approved a follow-on version of rhGH called Onmitrope (Sandoz). A sustained-release form of growth hormone, Nutropin Depot (Genentech and Alkermes) was approved by the FDA in 1999, allowing for fewer injections (every 2 or 4 weeks instead of daily); the product was discontinued in 2004.

RuneScape is a Java-based MMORPG operated by Jagex Ltd. With over nine million active free accounts and more than one million paid member accounts, RuneScape is rated among the most popular online games in the world. More than five million unique players access their accounts to play RuneScape at least once per month. RuneScape offers both free and subscription content and is designed to be accessible from any location with an Internet connection and to run in an ordinary web browser without straining system resources. One of the best website that discussed various gamers' issues is IJFG.com IJFG.COM Internet Junction For Gamers Internet Junction For Gamers, Runescape Market and More IJFG.COM This site has Jokes, Pranks, Runescape and other cool games at IJFG.COM. RuneScape is set in a medieval fantasy world, similar to "Guild Wars" or "EverQuest", where players control character representations of themselves. As with most massive multiplayer online roleplaying games (MMORPG), there is no overall objective or end to the game. Players explore, form alliances, perform optional tasks, and complete quests for rewards and to build character's skills. Internet Junction For Gamers, Runescape Market and More. IJFG.com IJFG.com RuneScape takes place in the fantasy-themed realm of Gielinor, which is divided into several different kingdoms, regions, and areas. Players can travel throughout the gaming world on foot, by using magical teleportation spells or devices, or mechanical means of transportation. Each region offers different types of monsters, materials, and quests to challenge players. Players are shown on the screen as customisable avatars. They set their own goals and objectives, deciding which of the available activities to pursue. There is no linear path that must be followed. Players can engage in combat with other players or with monsters, complete quests, or increase their experience in any of the available skills. Players interact with each other through trading, chatting, or playing combative or cooperative mini-games. Internet Junction For Gamers, Runescape Market and More IJFG.COM IJFG.com . Another useful site is Humf Runescape guide and help. HUMF.com. This site is about runescape, runescape help, runescape tips, runescape forum, runescape forums, runscape fan, runescape fan site, runescape guide, runescape guides, runescape chat, runescape clan runescape help and guide forums at HUMF.com

Contact Information

Call our office today to set up an appointment. Learn more about how we can help you, and learn more about the other services that we can offer you. All messages we receive will be answered as soon as possible. We look forward to hearing from you.

Electronic mail: General Information: